Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -405.70x is 248% below its 5-year average of -116.49x, near the high end of its 5-year range (-1850.00x–-15.05x).
15.79% above its 12-month average of -481.75x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -15.05x.
INTEREST COVERAGE RATIO
-405.70x
INTEREST COVERAGE RATIO AVG TTM
-481.75x
INTEREST COVERAGE RATIO AVG 3Y
-175.42x
INTEREST COVERAGE RATIO AVG 5Y
-116.49x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+15.79%
CURRENT VS 3Y AVG
-131.28%
CURRENT VS 5Y AVG
-248.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-6199.69%
vs the sector median at left
Spruce Biosciences, Inc.
Market Cap
$117.76M
Interest Coverage Ratio
-405.70x
TTM Avg
-481.75x
3Y Avg
-175.42x
5Y Avg
-116.49x
Market Cap
$118.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$118.83M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$115.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.58M
Interest Coverage Ratio
-41.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.46M
Interest Coverage Ratio
-2256.36x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spruce Biosciences, Inc. (SPRB) | $117.76M | -405.70x | -481.75x | -175.42x | -116.49x |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | N/A | N/A | N/A | N/A |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | N/A | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | N/A | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $119.84M | -1.90x | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | N/A | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $120.41M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | -41.14x | N/A | N/A | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.46M | -2256.36x | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $113.89M | N/A | N/A | N/A | N/A |
Interest Coverage
-405.7x
Debt/Equity
0.09
Current Ratio
9.23
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -15.05x |
| 2026-03-31 | -17.78x |
| 2025-12-31 | -1850.00x |
| 2025-09-30 | -433.11x |
| 2025-06-30 | -92.83x |
| 2025-03-31 | -402.56x |
| 2024-12-31 | -429.89x |
| 2024-09-30 | -132.51x |
| 2024-06-30 | -120.92x |
| 2024-03-31 | -130.24x |
| 2023-12-31 | -105.32x |
| 2023-09-30 | -114.77x |
| 2023-06-30 | -110.02x |
| 2023-03-31 | -100.76x |
| 2022-12-31 | -93.88x |
| 2022-09-30 | -105.06x |
| 2022-06-30 | -126.40x |
| 2022-03-31 | -134.86x |
| 2021-12-31 | -103.81x |
| 2021-09-30 | -129.55x |
| 2021-06-30 | -146.43x |
| 2021-03-31 | -110.30x |
| 2020-12-31 | -106.86x |
| 2020-09-30 | -121.00x |
| 2020-06-30 | -69.45x |
| 2020-03-31 | -69.36x |
| 2019-12-31 | -52.23x |
| 2019-09-30 | -512.80x |
